Trials / Completed
CompletedNCT05392556
Prebiotic and Probiotic Modulation of the Gut Microbiota-gut-brain Axis During Acute Stress
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 73 (actual)
- Sponsor
- United States Army Research Institute of Environmental Medicine · Federal
- Sex
- All
- Age
- 17 Years – 39 Years
- Healthy volunteers
- Accepted
Summary
Emerging evidence supports the existence of a microbiota-gut-brain axis through which gut microbes influence cognition, mood and behavior. Targeting this axis with probiotics and/or prebiotics may provide novel strategies for mitigating stress-induced decrements in gastrointestinal and cognitive function. This double-blind, placebo-controlled, randomized, parallel-arm trial will determine the effects of a prebiotic and a probiotic dietary intervention on gastrointestinal, cognitive and physiologic responses to acute military-relevant physical and cognitive stress. Healthy men and women will be recruited and randomized to receive a placebo, probiotic or prebiotic for 4wk. Volunteers will be fed a controlled diet during the 4th week of supplementation. Fecal, blood, urine and saliva samples will be collected. Physical stress will be induced by a weighted walk on a treadmill, and will be followed by a cognitively challenging testing scenario that uses intermittent electric shocks to the abdomen to induce a stress response.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Probiotic | Cerebiome (Lallemand Health Solutions): probiotic supplement containing Bifidobacterium longum R0175, Lactobacillus helveticus R0052, and maltodextrin. Dosing: Oral, 3.6 g/d containing 3x10\^9 CFU/d (powder form) |
| DIETARY_SUPPLEMENT | Prebiotic | Bimuno-GOS (Clasado Biosciences): Dosing: Oral; 3.6 g/d containing 2.75 g active GOS/d (powder form) |
| OTHER | Placebo | Maltodextrin 3.6 g/d (powder form) |
Timeline
- Start date
- 2022-07-06
- Primary completion
- 2025-10-28
- Completion
- 2025-10-28
- First posted
- 2022-05-26
- Last updated
- 2025-12-26
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05392556. Inclusion in this directory is not an endorsement.